Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

RPR and Targacept enter agreement to develop AD and PD treatments

Feb. 11, 1999

Inadvertent overdoses of Cerebyx due to labeling confusion lead to death

Feb. 10, 1999

Effects of NS-105 on cAMP production involve different mGluR groups

Feb. 10, 1999

Effects of NS-7 on Ca2+ channel subtypes and NOS

Feb. 10, 1999

Avanir signs letter of intent with IriSys for ALS drug

Feb. 10, 1999

Neuroprotective effects of FK-506 in rat stroke model not mediated by suppression of NO production

Feb. 9, 1999

Animal study supports cognition-enhancing efficacy of nefiracetam following ischemia

Feb. 9, 1999

NIH researchers determine 3-D structure of melatonin enzyme

Feb. 9, 1999

IOCM approves Rebif for MS

Feb. 9, 1999

UCB files NDA for levetiracetam

Feb. 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...